TCP11L1
gene geneOn this page
Also known as FLJ11336
Summary
TCP11L1 (t-complex 11 like 1, HGNC:25655) is a protein-coding gene on chromosome 11p13, encoding T-complex protein 11-like protein 1 (Q9NUJ3).
Predicted to be involved in signal transduction. Located in microtubule.
Source: NCBI Gene 55346 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 67 total
- MANE Select transcript:
NM_018393
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25655 |
| Approved symbol | TCP11L1 |
| Name | t-complex 11 like 1 |
| Location | 11p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ11336 |
| Ensembl gene | ENSG00000176148 |
| Ensembl biotype | protein_coding |
| Entrez | 55346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 11 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000334274, ENST00000432887, ENST00000527661, ENST00000528107, ENST00000528898, ENST00000528962, ENST00000530171, ENST00000530419, ENST00000531632, ENST00000532687, ENST00000602733, ENST00000862423, ENST00000862424, ENST00000949219, ENST00000949220
RefSeq mRNA: 2 — MANE Select: NM_018393
NM_001145541, NM_018393
CCDS: CCDS7882
Canonical transcript exons
ENST00000334274 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001612247 | 33054593 | 33054725 |
| ENSE00002142261 | 33039572 | 33039792 |
| ENSE00003478120 | 33068687 | 33068859 |
| ENSE00003485810 | 33058959 | 33059095 |
| ENSE00003501420 | 33057919 | 33058139 |
| ENSE00003583607 | 33061530 | 33061726 |
| ENSE00003662531 | 33057115 | 33057235 |
| ENSE00003684938 | 33065830 | 33066011 |
| ENSE00003799950 | 33043750 | 33043936 |
| ENSE00003845903 | 33072474 | 33073550 |
Expression profiles
Bgee: expression breadth ubiquitous, 214 present calls, max score 88.24.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.3157 / max 287.0723, expressed in 1806 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 113651 | 12.3729 | 1789 |
| 113658 | 2.6470 | 1145 |
| 113653 | 1.1515 | 724 |
| 113656 | 0.9137 | 610 |
| 113650 | 0.7724 | 429 |
| 113659 | 0.7339 | 468 |
| 113652 | 0.5743 | 322 |
| 113657 | 0.3865 | 188 |
| 113649 | 0.3067 | 140 |
| 113654 | 0.2955 | 104 |
Top tissues by expression
270 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.24 | gold quality |
| vena cava | UBERON:0004087 | 87.85 | silver quality |
| type B pancreatic cell | CL:0000169 | 87.35 | gold quality |
| olfactory bulb | UBERON:0002264 | 86.96 | gold quality |
| diaphragm | UBERON:0001103 | 85.54 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.89 | gold quality |
| triceps brachii | UBERON:0001509 | 84.57 | gold quality |
| corpus callosum | UBERON:0002336 | 84.16 | gold quality |
| parotid gland | UBERON:0001831 | 84.03 | silver quality |
| colonic epithelium | UBERON:0000397 | 83.97 | gold quality |
| prefrontal cortex | UBERON:0000451 | 83.96 | gold quality |
| gluteal muscle | UBERON:0002000 | 83.58 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 83.53 | gold quality |
| tendon | UBERON:0000043 | 83.35 | gold quality |
| stromal cell of endometrium | CL:0002255 | 83.12 | gold quality |
| male germ cell | CL:0000015 | 82.66 | gold quality |
| sperm | CL:0000019 | 82.02 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 82.02 | gold quality |
| cortical plate | UBERON:0005343 | 81.45 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 81.45 | gold quality |
| bone marrow cell | CL:0002092 | 81.26 | gold quality |
| monocyte | CL:0000576 | 80.87 | gold quality |
| hair follicle | UBERON:0002073 | 80.82 | gold quality |
| mononuclear cell | CL:0000842 | 80.74 | gold quality |
| leukocyte | CL:0000738 | 80.53 | gold quality |
| gall bladder | UBERON:0002110 | 80.45 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.45 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 79.96 | gold quality |
| popliteal artery | UBERON:0002250 | 79.87 | gold quality |
| tibial artery | UBERON:0007610 | 79.86 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
80 targeting TCP11L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tcp11l1 | ENSDARG00000031890 |
| mus_musculus | Tcp11l1 | ENSMUSG00000027175 |
| rattus_norvegicus | Tcp11l1 | ENSRNOG00000042576 |
| drosophila_melanogaster | CG16721 | FBGN0029820 |
| caenorhabditis_elegans | WBGENE00010875 |
Paralogs (4): TCP11 (ENSG00000124678), TCP11L2 (ENSG00000166046), TCP11X2 (ENSG00000215029), TCP11X1 (ENSG00000268235)
Protein
Protein identifiers
T-complex protein 11-like protein 1 — Q9NUJ3 (reviewed: Q9NUJ3)
All UniProt accessions (7): Q9NUJ3, E9PJ55, E9PMB0, E9PP52, E9PS88, H0YES4, R4GNF5
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the TCP11 family.
RefSeq proteins (2): NP_001139013, NP_060863* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008862 | Tcp11 | Family |
Pfam: PF05794
UniProt features (6 total): sequence variant 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NUJ3-F1 | 82.20 | 0.59 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 56
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 72 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, SENESE_HDAC1_AND_HDAC2_TARGETS_DN, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, BASAKI_YBX1_TARGETS_UP, SENESE_HDAC3_TARGETS_DN, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12, FORTSCHEGGER_PHF8_TARGETS_DN, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GOCC_SUPRAMOLECULAR_POLYMER, CIITA_TARGET_GENES, DACH1_TARGET_GENES, E2F5_TARGET_GENES, HOXB4_TARGET_GENES
GO Biological Process (1): signal transduction (GO:0007165)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): microtubule (GO:0005874)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| binding | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
447 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TCP11L1 | CCDC73 | Q6ZRK6 | 645 |
| TCP11L1 | QSER1 | Q2KHR3 | 618 |
| TCP11L1 | DEPDC7 | Q96QD5 | 609 |
| TCP11L1 | PRRG4 | Q9BZD6 | 584 |
| TCP11L1 | CSTF3 | Q12996 | 558 |
| TCP11L1 | EIF3M | Q7L2H7 | 527 |
| TCP11L1 | COMMD9 | Q9P000 | 517 |
| TCP11L1 | C11orf91 | Q3C1V1 | 507 |
| TCP11L1 | DNAJC24 | Q6P3W2 | 488 |
| TCP11L1 | ARL14EP | Q8N8R7 | 475 |
| TCP11L1 | CCDC47 | Q96A33 | 472 |
| TCP11L1 | ELP4 | Q96EB1 | 450 |
| TCP11L1 | MYZAP | P0CAP1 | 430 |
| TCP11L1 | SMIM14 | Q96QK8 | 419 |
| TCP11L1 | CCDC34 | Q96HJ3 | 405 |
IntAct
138 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARPC5 | ARPC3 | psi-mi:“MI:0914”(association) | 0.730 |
| TUBB | PLD2 | psi-mi:“MI:0914”(association) | 0.640 |
| VPS52 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HMG20A | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX1 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REL | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PAX6 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ERCC6L2 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGEA12 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX2 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBX6 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCP11L1 | CNOT7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DDIT4L | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRXL2B | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSNAX | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PSMD4 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNW1 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IPO4 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCP11L1 | PLEKHS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP2 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM21 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| WWTR1 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRSS22 | PPM1A | psi-mi:“MI:0914”(association) | 0.560 |
| TUBB3 | POTEF | psi-mi:“MI:0914”(association) | 0.530 |
| TUBB2B | EML2 | psi-mi:“MI:0914”(association) | 0.530 |
| TTC5 | TUBA4A | psi-mi:“MI:0914”(association) | 0.530 |
| FAM174A | BLTP3B | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (89): TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-RNA), TCP11L1 (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS)
ESM2 similar proteins: A0JMW6, A1L1K3, A1L2I9, A2BID5, A2RV06, A7Z033, B4DZS4, O70481, O75153, P52590, P57740, Q01755, Q08CY4, Q0IHW8, Q14746, Q2PW47, Q568Z0, Q5BLE2, Q5FWU8, Q5H9J9, Q5PQS3, Q5SW19, Q5U249, Q5XI00, Q62825, Q68F70, Q68Y81, Q6GPP1, Q6GR21, Q6IV68, Q6KAR6, Q6NRB7, Q7SYB2, Q7T0S7, Q80V62, Q8BH74, Q8BTG3, Q8CDT7, Q8CIM8, Q8IWV7
Diamond homologs: A7Z033, B4DZS4, Q01755, Q568Z0, Q5H9J9, Q5XI00, Q8BTG3, Q8K1H7, Q8N4U5, Q8WWU5, Q9NUJ3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 117 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 13 | 104.0× | 1e-22 |
| Transport of connexons to the plasma membrane | 13 | 104.0× | 1e-22 |
| Gap junction trafficking and regulation | 13 | 91.0× | 6e-22 |
| Gap junction trafficking | 13 | 91.0× | 6e-22 |
| Post-chaperonin tubulin folding pathway | 13 | 91.0× | 6e-22 |
| Formation of tubulin folding intermediates by CCT/TriC | 13 | 80.9× | 4e-21 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 13 | 78.0× | 7e-21 |
| Activation of AMPK downstream of NMDARs | 13 | 72.8× | 2e-20 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| microtubule cytoskeleton organization | 17 | 21.0× | 2e-15 |
| mitotic cell cycle | 14 | 19.1× | 5e-12 |
| cerebral cortex development | 6 | 12.6× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3026 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:33043937:G:GG | donor_gain | 1.0000 |
| 11:33054586:GTTAC:G | acceptor_loss | 1.0000 |
| 11:33054587:TTACA:T | acceptor_loss | 1.0000 |
| 11:33054589:ACAG:A | acceptor_loss | 1.0000 |
| 11:33054590:CA:C | acceptor_loss | 1.0000 |
| 11:33054591:A:AG | acceptor_gain | 1.0000 |
| 11:33054592:G:GA | acceptor_gain | 1.0000 |
| 11:33054592:GCT:G | acceptor_gain | 1.0000 |
| 11:33054592:GCTA:G | acceptor_gain | 1.0000 |
| 11:33054724:AGGT:A | donor_loss | 1.0000 |
| 11:33054726:G:GG | donor_gain | 1.0000 |
| 11:33054726:GTA:G | donor_loss | 1.0000 |
| 11:33054727:T:A | donor_loss | 1.0000 |
| 11:33057105:A:AG | acceptor_gain | 1.0000 |
| 11:33057105:ACT:A | acceptor_gain | 1.0000 |
| 11:33057106:C:G | acceptor_gain | 1.0000 |
| 11:33057107:T:A | acceptor_gain | 1.0000 |
| 11:33057913:TTGTA:T | acceptor_loss | 1.0000 |
| 11:33057917:A:AG | acceptor_gain | 1.0000 |
| 11:33057918:G:GG | acceptor_gain | 1.0000 |
| 11:33057918:G:GT | acceptor_loss | 1.0000 |
| 11:33057918:GA:G | acceptor_gain | 1.0000 |
| 11:33057918:GACT:G | acceptor_gain | 1.0000 |
| 11:33057938:T:A | acceptor_gain | 1.0000 |
| 11:33057942:T:TA | acceptor_gain | 1.0000 |
| 11:33058093:G:GT | donor_gain | 1.0000 |
| 11:33058097:T:G | donor_gain | 1.0000 |
| 11:33058111:GACAT:G | donor_gain | 1.0000 |
| 11:33058120:G:GT | donor_gain | 1.0000 |
| 11:33058121:A:T | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000066821 (11:33051333 A>G), RS1000141753 (11:33040111 T>C), RS1000212540 (11:33039277 A>G), RS1000486041 (11:33061079 C>T), RS1000486281 (11:33068096 T>C), RS1000513619 (11:33039954 G>A,C,T), RS1000669400 (11:33049891 C>G,T), RS1000684146 (11:33063126 G>A), RS1000820247 (11:33069657 C>G,T), RS1000843521 (11:33057337 A>G,T), RS1000959989 (11:33063812 G>A,T), RS1000976831 (11:33067478 T>C), RS1001082173 (11:33051279 T>G), RS1001248437 (11:33073754 T>A), RS1001281424 (11:33060829 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:258040
GenCC curated gene-disease
Mondo (1): exstrophy-epispadias complex (MONDO:0017919)
Orphanet (2): Exstrophy-epispadias complex (Orphanet:322), Cloacal exstrophy (Orphanet:93929)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002324_8 | Anger | 2.000000e-06 |
| GCST90002401_179 | Platelet distribution width | 1.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003015 | aggressive behavior |
| EFO:0007984 | platelet component distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression, increases mutagenesis | 4 |
| Valproic Acid | affects cotreatment, increases expression | 3 |
| Aflatoxin B1 | affects expression, increases expression, increases methylation | 2 |
| beauvericin | affects cotreatment, decreases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| sulforaphane | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| enniatins | affects cotreatment, decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Perfume | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT04760028 | PHASE4 | COMPLETED | Study on the Influencing Factors of Electroencephalogram Parameters Under Anesthesia |
| NCT06106425 | Not specified | UNKNOWN | Diagnostic and Prognostic Criteria of EEG in Neonatal Convulsions at Assiut University Children Hospital |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): exstrophy-epispadias complex